In the current study, the JAK2 copy gain determined by FISH and real-time PCR occurred frequently in the T-ALL cell lines and patients (Figure 1B, Figure 2B, Supplementary Figure 1), suggesting that this copy gain was the most common type of JAK2 activation in T-ALL. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.